Skip to menu Skip to content Skip to footer

Pre-clinical validation of a novel target for host-directed therapy for the treatment of Tuberculosis (2020)

Experts

Honorary Professor Katharina Ronacher

Professor, Honorary
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Honorary Associate Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Katharina Ronacher
Katharina Ronacher